Literature DB >> 19361505

Heparin-binding EGF-like growth factor increases intestinal microvascular blood flow in necrotizing enterocolitis.

Xiaoyi Yu1, Andrei Radulescu, Nicholas Zorko, Gail E Besner.   

Abstract

BACKGROUND & AIMS: Necrotizing enterocolitis (NEC) is the most common gastrointestinal emergency in neonates. Although the exact etiology remains unknown, decreased intestinal blood flow is believed to play a critical role. We have shown that heparin-binding epidermal growth factor-like growth factor (HB-EGF) protects the intestines from injury in a rodent model of NEC. Our current goal was to assess the effect of HB-EGF on intestinal microvascular blood flow and intestinal injury in rat pups subjected to experimental NEC.
METHODS: Newborn rat pups were subjected to stress by exposure to hypoxia, hypothermia, hypertonic feedings, and lipopolysaccharide, with some pups receiving HB-EGF (800 microg x kg(-1) x dose(-1)) added to the feeds. Control animals received breast milk. Intestinal injury was graded using a standard histologic injury scoring system. Microvascular blood flow was assessed by fluorescein isothiocyanate/dextran angiography, with fluorescent images subjected to quantification, and by scanning electron microscopy.
RESULTS: Intestinal microvascular blood flow (defined as the extent of vascular filling with fluorescein isothiocyanate/dextran) was significantly decreased in pups subjected to stress compared with breast-fed pups. Stressed pups treated with HB-EGF had significantly increased microvascular blood flow. The changes in villous microvasculature correlated with histologic injury scores, with stressed pups treated with HB-EGF showing decreased histologic injury.
CONCLUSIONS: HB-EGF significantly preserved intestinal microvascular blood flow in pups subjected to experimental NEC, indicating that HB-EGF may play a critical role in the treatment of various diseases manifested by decreased intestinal blood flow, including NEC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19361505      PMCID: PMC2704259          DOI: 10.1053/j.gastro.2009.03.060

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  46 in total

Review 1.  Regulation of intestinal blood flow.

Authors:  P J Matheson; M A Wilson; R N Garrison
Journal:  J Surg Res       Date:  2000-09       Impact factor: 2.192

2.  N-arginine dibasic convertase is a specific receptor for heparin-binding EGF-like growth factor that mediates cell migration.

Authors:  E Nishi; A Prat; V Hospital; K Elenius; M Klagsbrun
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

3.  Heparin-binding EGF-like growth factor decreases apoptosis in intestinal epithelial cells in vitro.

Authors:  M P Michalsky; A Kuhn; V Mehta; G E Besner
Journal:  J Pediatr Surg       Date:  2001-08       Impact factor: 2.545

4.  Correlation of VEGF and angiopoietin expression with disruption of blood-brain barrier and angiogenesis after focal cerebral ischemia.

Authors:  Zheng Gang Zhang; Li Zhang; Wayne Tsang; Hamid Soltanian-Zadeh; Daniel Morris; Ruilan Zhang; Anton Goussev; Cecylia Powers; Thomas Yeich; Michael Chopp
Journal:  J Cereb Blood Flow Metab       Date:  2002-04       Impact factor: 6.200

5.  Gastroprotective and vasodilatory effects of epidermal growth factor: the role of sensory afferent neurons.

Authors:  Y Matsumoto; K Kanamoto; K Kawakubo; H Aomi; T Matsumoto; S Ibayashi; M Fujishima
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-05       Impact factor: 4.052

6.  Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells.

Authors:  Thaddeus S Stappenbeck; Lora V Hooper; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-13       Impact factor: 11.205

7.  Intestinal microvascular patterns during hemorrhagic shock.

Authors:  S Morini; W Yacoub; C Rastellini; E Gaudio; S C Watkins; L Cicalese
Journal:  Dig Dis Sci       Date:  2000-04       Impact factor: 3.199

8.  Heparin-binding epidermal growth factor-like growth factor protects rat intestine from ischemia/reperfusion injury.

Authors:  S B Pillai; C E Hinman; M H Luquette; P T Nowicki; G E Besner
Journal:  J Surg Res       Date:  1999-12       Impact factor: 2.192

9.  Heparin-binding EGF-like growth factor (HB-EGF) decreases oxygen free radical production in vitro and in vivo.

Authors:  M Ann Kuhn; Guilang Xia; Veela B Mehta; Sandra Glenn; Marc P Michalsky; Gail E Besner
Journal:  Antioxid Redox Signal       Date:  2002-08       Impact factor: 8.401

10.  Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis.

Authors:  M S Caplan; X M Sun; W Hseuh; J R Hageman
Journal:  J Pediatr       Date:  1990-06       Impact factor: 4.406

View more
  49 in total

1.  Heparin-binding epidermal growth factor-like growth factor overexpression in transgenic mice increases resistance to necrotizing enterocolitis.

Authors:  Andrei Radulescu; Hong-Yi Zhang; Xiaoyi Yu; Jacob K Olson; Amanda K Darbyshire; Yan Chen; Gail E Besner
Journal:  J Pediatr Surg       Date:  2010-10       Impact factor: 2.545

2.  Heparin-binding EGF-like growth factor protects pericytes from injury.

Authors:  Xiaoyi Yu; Andrei Radulescu; Chun-Liang Chen; Iyore O James; Gail E Besner
Journal:  J Surg Res       Date:  2010-09-17       Impact factor: 2.192

3.  Heparin-binding epidermal growth factor-like growth factor restores Wnt/β-catenin signaling in intestinal stem cells exposed to ischemia/reperfusion injury.

Authors:  Chun-Liang Chen; Jixin Yang; Iyore O A James; Hong-Yi Zhang; Gail E Besner
Journal:  Surgery       Date:  2014-02-06       Impact factor: 3.982

4.  Endothelial TLR4 activation impairs intestinal microcirculatory perfusion in necrotizing enterocolitis via eNOS-NO-nitrite signaling.

Authors:  Ibrahim Yazji; Chhinder P Sodhi; Elizabeth K Lee; Misty Good; Charlotte E Egan; Amin Afrazi; Matthew D Neal; Hongpeng Jia; Joyce Lin; Congrong Ma; Maria F Branca; Thomas Prindle; Ward M Richardson; John Ozolek; Timothy R Billiar; David G Binion; Mark T Gladwin; David J Hackam
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-06       Impact factor: 11.205

5.  Animal models of gastrointestinal and liver diseases. Animal models of necrotizing enterocolitis: pathophysiology, translational relevance, and challenges.

Authors:  Peng Lu; Chhinder P Sodhi; Hongpeng Jia; Shahab Shaffiey; Misty Good; Maria F Branca; David J Hackam
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-04-24       Impact factor: 4.052

6.  Are EGF and TLR-4 crucial to understanding the link between milk and NEC?

Authors:  J P M Derikx; B W Kramer; T G A M Wolfs
Journal:  Mucosal Immunol       Date:  2015-06-03       Impact factor: 7.313

Review 7.  Heparin-Binding Epidermal Growth Factor-Like Growth Factor as a Critical Mediator of Tissue Repair and Regeneration.

Authors:  Duy T Dao; Lorenzo Anez-Bustillos; Rosalyn M Adam; Mark Puder; Diane R Bielenberg
Journal:  Am J Pathol       Date:  2018-08-22       Impact factor: 4.307

Review 8.  Pathogenesis of NEC: Role of the innate and adaptive immune response.

Authors:  Timothy L Denning; Amina M Bhatia; Andrea F Kane; Ravi M Patel; Patricia W Denning
Journal:  Semin Perinatol       Date:  2016-12-09       Impact factor: 3.300

Review 9.  The role of growth factors in intestinal regeneration and repair in necrotizing enterocolitis.

Authors:  Kathryn J Rowland; Pamela M Choi; Brad W Warner
Journal:  Semin Pediatr Surg       Date:  2013-05       Impact factor: 2.754

Review 10.  The role of the intestinal microcirculation in necrotizing enterocolitis.

Authors:  Daniel J Watkins; Gail E Besner
Journal:  Semin Pediatr Surg       Date:  2013-05       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.